cystine has been researched along with Pancreatic Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, H; Ferri, V; Gambhir, SS; Goel, M; Hatami, N; Haywood, T; Iagaru, A; Kellow, R; Kimura, R; Nakamoto, R; Park, W; Rosenberg, J; Shen, B; Wardak, M | 1 |
| DeNicola, GM; Hao, J; Hempel, N; Huang, C; Lan, C; Li, Y; Li, Z; Lin, S; Singh, PK; Sun, D; Sun, J; Trebak, M; Wang, H; Wang, X; Wu, L; Yang, S | 1 |
| Andrade, LR; Badgley, MA; Decker, AR; DelGiorno, KE; Firl, CEM; Georgiou, G; Gu, W; Hirschhorn, T; Iuga, A; Kapilian, J; Kremer, DM; Lamb, C; Lee, HJ; Liu, T; Lyssiotis, CA; Ma, A; Manor, U; Maurer, HC; Olive, KP; Palermo, CF; Purohit, V; Sagalovskiy, IR; Sajjakulnukit, P; Sastra, SA; Seeley, ES; Stockwell, BR; Stone, E; Tolstyka, ZP; Wahl, GM; Zhang, L | 1 |
| Cassim, S; Daher, B; Parks, S; Pouyssegur, J; Vucetic, M | 1 |
| Andren, AC; Asara, JM; Badgley, MA; Carpenter, ES; Crawford, HC; Cusmano, N; Das, NK; di Magliano, MP; Gao, T; Halbrook, CJ; Hou, SW; Kerk, SA; Kremer, DM; Lin, L; Little, AC; Lyssiotis, CA; Magnuson, B; Mbah, NE; McBrayer, SK; Myers, A; Nelson, BS; Nwosu, ZC; Olive, KP; Palermo, CF; Ramos, J; Sajjakulnukit, P; Sastra, SA; Savani, MR; Shah, YM; Shan, M; Thurston, G; Wisner, S; Yarosz, EL; Zhang, L | 1 |
| Denny, C; Federman, N; Girgis, MD; McCabe, KE; Nagy, JO; Rochefort, MM; Tomlinson, JS; Wu, AM | 1 |
| Guerrero Gual, M; Michalopoulou Alevras, T; Pérez-Maraver, M; Villabona Artero, C | 1 |
| Gout, PW; Ling, V; Lo, M; Wang, YZ | 1 |
| Boytim, ML; Cohen, SJ; Conkling, P; Davis, P; Dorr, RT; Hersh, EM; Modiano, MR; Patt, YZ; Zalupski, MM | 1 |
| Doi, K | 1 |
1 trial(s) available for cystine and Pancreatic Neoplasms
| Article | Year |
|---|---|
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cohort Studies; Cystine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Half-Life; Hexanones; Humans; Male; Middle Aged; Pancreatic Neoplasms; Sulfhydryl Compounds; Tomography, X-Ray Computed | 2010 |
9 other study(ies) available for cystine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Pilot-phase PET/CT study targeting integrin α
Topics: Cystine; Cystine-Knot Miniproteins; Female; Humans; Male; Pancreatic Neoplasms; Peptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution | 2022 |
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer.
Topics: Calcium; Calcium Channels; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cystine; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Pancreatic Neoplasms | 2022 |
Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cationic Amino Acid Transporter 1; Cell Line, Tumor; Cystathionine gamma-Lyase; Cysteine; Cystine; Ferroptosis; Gene Deletion; Humans; Mice; Mice, Mutant Strains; Pancreatic Neoplasms | 2020 |
Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors.
Topics: Carcinoma, Pancreatic Ductal; Cell Death; Cystine; Humans; Oxidation-Reduction; Pancreatic Neoplasms | 2021 |
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis.
Topics: Animals; Antioxidants; Aspartate Aminotransferase, Cytoplasmic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystine; Ferroptosis; Glutathione; Humans; Iron; Mice; Mitochondria; Pancreatic Neoplasms | 2021 |
An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
Topics: Animals; Antibodies, Bispecific; CA-19-9 Antigen; Cell Line, Tumor; Cystine; Female; Humans; Immunotherapy; Liposomes; Mice; Mice, Nude; Multiple Myeloma; Nanoparticles; Pancreatic Neoplasms; Positron-Emission Tomography; Protein Engineering; Single-Chain Antibodies; Xenograft Model Antitumor Assays | 2013 |
[Autoimmune hypoglycemia syndrome associated with α lipoic acid consumption].
Topics: Alopecia; Antioxidants; Autoimmune Diseases; Cystine; Diagnosis, Differential; Dietary Supplements; Female; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Insulin; Insulinoma; Islets of Langerhans; Middle Aged; Pancreatic Neoplasms; Sulfhydryl Compounds; Thioctic Acid | 2015 |
The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Line, Tumor; Cystine; Deoxycytidine; DNA Primers; Drug Resistance, Neoplasm; Gemcitabine; Glutathione; Humans; Immunohistochemistry; Microscopy, Fluorescence; Oxidative Stress; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; Dimethylnitrosamine; Fatty Acids, Nonesterified; Glutathione; Guinea Pigs; Insulin; Islets of Langerhans; Male; Mannoheptulose; Mice; NAD; Niacinamide; Nicotinic Acids; Pancreatic Neoplasms; Picolinic Acids; Pyrazinamide; Rabbits; Rats; Streptozocin; Tolbutamide; Uric Acid | 1975 |